Clinical and Laboratory Parameters of Mast Cell Activation as Basis for the Formulation of Diagnostic CriteriaVALENT, Peter; HORNY, Hans-Peter; TRIGGIANI, Massimo et al.International archives of allergy and immunology. 2011, Vol 156, Num 2, pp 119-127, issn 1018-2438, 9 p.Article

Role of iron in tumor cell protection from the pro-apoptotic effect of nitric oxideFEGER, Fredéric; FERRY-DUMAZET, Hélène; REIFFERS, Josy et al.Cancer research (Baltimore). 2001, Vol 61, Num 13, pp 5289-5294, issn 0008-5472Article

Kit signaling and negative regulation of daunorubicin-induced apoptosis : role of phospholipase CγPLO, Isabelle; LAUTIER, Dominique; CASTERAN, Nathalie et al.Oncogene (Basingstoke). 2001, Vol 20, Num 46, pp 6752-6763, issn 0950-9232Article

Rapamycin inhibits growth and survival of D816V-mutated c-kit mast cellsGABILLOT-CARRE, Marion; LEPELLETIER, Yves; BAUDE, Cédric et al.Blood. 2006, Vol 108, Num 3, pp 1065-1072, issn 0006-4971, 8 p.Article

Mast cells as a source and target for nitric oxide : Nitric oxide in immunity and inflammationBIDRI, Mohamed; FEGER, Frédéric; VARADARADJALOU, Sonia et al.International immunopharmacology. 2001, Vol 1, Num 8, pp 1543-1558, issn 1567-5769Article

Referent D-dimer enzyme-linked immunosorbent assay testing is of limited value in the exclusion of thromboembolic disease : result of a practical study in an EDRAY, Patrick; BELLICK, Bensalem; BIROLLEAU, Sophie et al.The American journal of emergency medicine. 2006, Vol 24, Num 3, pp 313-318, issn 0735-6757, 6 p.Article

Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteriaVALENT, Peter; AKIN, Cem; SPERR, Wolfgang R et al.Leukemia research. 2003, Vol 27, Num 7, pp 635-641, issn 0145-2126, 7 p.Article

Signal transduction: Associated and cell activation: Linked antigens expressed in human mast cellsVALENT, Peter; GHANNADAN, Minoo; HAUSWIRTH, Alexander W et al.International journal of hematology. 2002, Vol 75, Num 4, pp 357-362, issn 0925-5710Article

Pediatric Mastocytosis Is a Clonal Disease Associated with D⁸¹⁶V and Other Activating c-KIT MutationsBODEMER, Christine; HERMINE, Olivier; LAUNAY, Jean-Marie et al.Journal of investigative dermatology. 2010, Vol 130, Num 3, pp 804-815, issn 0022-202X, 12 p.Article

Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-kit receptors found in mast cell neoplasmsZERMATI, Yael; DE SEPULVEDA, Paulo; PARIZOT, Christophe et al.Oncogene (Basingstoke). 2003, Vol 22, Num 5, pp 660-664, issn 0950-9232, 5 p.Article

Identical abnormality of the short arm of chromosome 18 in two philadelphia-positive chronic myelocytic leukemia patients with erythroblastic transformation, resulting in duplication of BCR-ABL1 fusionNGUYEN KHAC, Florence; WAILL, Marie-Christine; MERLE-BERAL, Hélène et al.Cancer genetics and cytogenetics. 2002, Vol 138, Num 1, pp 22-26, issn 0165-4608Article

Kit and C-kit mutations in mastocytosis: A short overview with special reference to novel molecular and diagnostic conceptsFEGER, Frédéric; RIBADEAU DUMAS, Antoine; LERICHE, Laurence et al.International archives of allergy and immunology. 2002, Vol 127, Num 2, pp 110-114, issn 1018-2438Article

Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromesVALENT, Peter; KLION, Amy D; BUTTERFIELD, Joseph H et al.Journal of allergy and clinical immunology. 2012, Vol 130, Num 3, pp 607-612, issn 0091-6749, 6 p.Article

Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus ProposalVALENT, Peter; AKIN, Cem; NEDOSZYTKO, Boguslaw et al.International archives of allergy and immunology. 2012, Vol 157, Num 3, pp 215-225, issn 1018-2438, 11 p.Article

H₄ histamine receptor mediates optimal migration of mast cell precursors to CXCL12GODOT, Veronique; AROCK, Michel; GARCIA, Gilles et al.Journal of allergy and clinical immunology. 2007, Vol 120, Num 4, pp 827-834, issn 0091-6749, 8 p.Article

Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cellsGARNACHE-OTTOU, Francine; CHAPEROT, Laurence; JACOB, Marie-Christine et al.Blood. 2005, Vol 105, Num 3, pp 1256-1264, issn 0006-4971, 9 p.Article

Diagnosis and treatment of systemic mastocytosis: State of the artVALENT, Peter; AKIN, Cem; SPERR, Wolfgang R et al.British journal of haematology. 2003, Vol 122, Num 5, pp 695-717, issn 0007-1048, 23 p.Article

Autocrine regulation of cord blood-derived human mast cell activation by IL-10ROYER, Bernard; VARADARADJALOU, A. Sonia; SAAS, Philippe et al.Journal of allergy and clinical immunology. 2001, Vol 108, Num 1, pp 80-86, issn 0091-6749Article

Identification of heat shock protein 32 (Hsp32) as a novel survival factor and therapeutic target in neoplastic mast cells. CommentaryAROCK, Michel A; KONDO, Rudin; PICKL, Winfried F et al.Blood. 2007, Vol 110, Num 2, issn 0006-4971, 471, 661-669 [10 p.]Article